• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AlF-NOTA-octreotide: first comparison with Ga-DOTATATE in a neuroendocrine tumour patient.

作者信息

Pauwels Elin, Cleeren Frederik, Tshibangu Térence, Koole Michel, Serdons Kim, Dekervel Jeroen, Van Cutsem Eric, Verslype Chris, Van Laere Koen, Bormans Guy, Deroose Christophe M

机构信息

Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.

出版信息

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399. doi: 10.1007/s00259-019-04425-1. Epub 2019 Jul 31.

DOI:10.1007/s00259-019-04425-1
PMID:31367905
Abstract
摘要

相似文献

1
AlF-NOTA-octreotide: first comparison with Ga-DOTATATE in a neuroendocrine tumour patient.AlF-NOTA-奥曲肽：首次在一名神经内分泌肿瘤患者中与镓[68Ga] DOTATATE进行比较。
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399. doi: 10.1007/s00259-019-04425-1. Epub 2019 Jul 31.
2
68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.68Ga-DOTATATE与111In-DTPA-奥曲肽及传统成像技术用于肺和胃肠胰神经内分泌肿瘤的比较：一项系统评价和Meta分析
J Nucl Med. 2016 Jun;57(6):872-8. doi: 10.2967/jnumed.115.165803. Epub 2016 Jan 14.
3
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy.罕见部位原发性软组织神经内分泌肿瘤伴转移，Lu-DOTATATE 治疗后近乎完全缓解：肽受体放射性核素治疗的有前景的临床应用实例。
J Nucl Med Technol. 2020 Mar;48(1):36-39. doi: 10.2967/jnmt.119.227058. Epub 2019 Aug 10.
4
Clinical and Prognostic Value of PET/CT Imaging with Combination of Ga-DOTATATE and F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms.胃胰神经内分泌肿瘤中 Ga-DOTATATE 与 F-FDG PET/CT 联合显像的临床及预后价值
Contrast Media Mol Imaging. 2018 Feb 26;2018:2340389. doi: 10.1155/2018/2340389. eCollection 2018.
5
Head-to-Head Comparison of Cu-DOTATATE and Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors.铜-多靶点肽（Cu-DOTATATE）与镓-多靶点肽（Ga-DOTATOC）PET/CT的头对头比较：59例神经内分泌肿瘤患者的前瞻性研究。
J Nucl Med. 2017 Mar;58(3):451-457. doi: 10.2967/jnumed.116.180430. Epub 2016 Sep 22.
6
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.(68)Ga-DOTATOC与(68)Ga-DOTATATE在胃肠胰神经内分泌肿瘤PET/CT中的摄取差异
Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18.
7
ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.ACR 实践参数：用于神经内分泌肿瘤的镓-68 DOTATATE PET/CT 性能。
Clin Nucl Med. 2018 Dec;43(12):899-908. doi: 10.1097/RLU.0000000000002309.
8
Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.68Ga-DOTATATE与18F-FDG PET/CT对神经内分泌肿瘤患者临床管理影响的比较
J Nucl Med. 2017 Jan;58(1):91-96. doi: 10.2967/jnumed.116.178095. Epub 2016 Aug 11.
9
The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.68Ga-DOTATATE PET 在 111In-DTPA-octreotide 闪烁扫描阴性或不确定的神经内分泌肿瘤患者中的作用。
J Nucl Med. 2010 Jun;51(6):875-82. doi: 10.2967/jnumed.109.066134. Epub 2010 May 19.
10
Clinical evaluation of [Ga]Ga-DATA-TOC in comparison to [Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours.[Ga]Ga-DATA-TOC 与 [Ga]Ga-DOTA-TOC 用于神经内分泌肿瘤患者的临床评估比较。
Nucl Med Biol. 2019 Sep-Oct;76-77:1-9. doi: 10.1016/j.nucmedbio.2019.08.006. Epub 2019 Aug 28.

引用本文的文献

1
Head-to-Head comparison of [F]AlF-NOTA-TATE and [Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors: a prospective study.[F]AlF-NOTA-TATE与[Ga]Ga-DOTA-TATE PET/CT在神经内分泌肿瘤患者中的头对头比较：一项前瞻性研究。
Eur J Nucl Med Mol Imaging. 2025 Sep 12. doi: 10.1007/s00259-025-07532-4.
2
Comparison of inter- and intraobserver agreement between [F]AlF-NOTA-octreotide and [Ga]Ga-DOTA-SSA PET/CT.[F]AlF-NOTA-奥曲肽与[Ga]Ga-DOTA-SSA PET/CT之间的观察者间和观察者内一致性比较。
EJNMMI Rep. 2025 May 15;9(1):17. doi: 10.1186/s41824-025-00250-y.
3
Research process of PET tracers for neuroendocrine tumors diagnosis.

本文引用的文献

1
Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms.18F-ALF-NOTA-Octreotide PET/CT 联合 18F-FDG PET/CT 在神经内分泌肿瘤影像中的临床应用。
Clin Nucl Med. 2019 Jun;44(6):452-458. doi: 10.1097/RLU.0000000000002578.
2
Somatostatin receptor PET ligands - the next generation for clinical practice.生长抑素受体PET配体——临床应用的新一代产品
Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):311-331. eCollection 2018.
3
Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions.
用于神经内分泌肿瘤诊断的正电子发射断层显像（PET）示踪剂的研究过程。
Am J Nucl Med Mol Imaging. 2025 Feb 25;15(1):1-14. doi: 10.62347/JXLY1661. eCollection 2025.
4
A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China.在中国进行的一项关于地努图希单抗β作为高危神经母细胞瘤患者一线维持治疗的临床观察研究。
BMC Pediatr. 2025 Mar 17;25(1):203. doi: 10.1186/s12887-025-05568-x.
5
Evaluation of the safety, biodistribution, dosimetry of [F]AlF-NOTA-LM3 and head-to-head comparison with [Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.[F]AlF-NOTA-LM3在高分化神经内分泌肿瘤患者中的安全性、生物分布、剂量测定评估以及与[Ga]Ga-DOTATATE的头对头比较：一项前瞻性试验的中期分析
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3719-3730. doi: 10.1007/s00259-024-06790-y. Epub 2024 Jun 15.
6
Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer.病例报告：177镥-多胺基多羧基大环配体-奥曲肽：一种治疗前列腺神经内分泌癌的新方案。
Front Oncol. 2023 Dec 11;13:1289272. doi: 10.3389/fonc.2023.1289272. eCollection 2023.
7
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE.新型 SSTR 靶向肽 [F]SiTATE 在脑膜瘤中的下一代 PET/CT 成像：初步临床经验。
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3390-3399. doi: 10.1007/s00259-023-06315-z. Epub 2023 Jun 26.
8
Al[F]F-NOTA-Octreotide Is Comparable to [Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population.Al[F]F-NOTA-奥曲肽在拉丁美洲人群神经内分泌肿瘤的PET/CT成像中与[Ga]Ga-DOTA-泰曲肽相当。
Cancers (Basel). 2023 Jan 10;15(2):439. doi: 10.3390/cancers15020439.
9
An optimized radiosynthesis of [ F]DK222, a PET radiotracer for imaging PD-L1.一种优化的 [ F]DK222 放射性合成方法，DK222 是一种用于 PD-L1 成像的正电子发射断层扫描（PET）放射性示踪剂。
J Labelled Comp Radiopharm. 2023 Feb;66(2):47-54. doi: 10.1002/jlcr.4012. Epub 2023 Jan 17.
10
Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design.氟-18：放射化学与靶向正电子发射断层显像分子探针设计
Front Chem. 2022 Jun 29;10:884517. doi: 10.3389/fchem.2022.884517. eCollection 2022.
胃肠胰神经内分泌肿瘤的分子成像：现状与未来方向
J Nucl Med. 2016 Dec;57(12):1949-1956. doi: 10.2967/jnumed.116.179234. Epub 2016 Nov 3.
4
A novel facile method of labeling octreotide with (18)F-fluorine.一种新型简便的奥曲肽（18）F-氟标记方法。
J Nucl Med. 2010 Mar;51(3):454-61. doi: 10.2967/jnumed.109.066902. Epub 2010 Feb 11.